Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issuance of Tranche 2 Loan Notes

15 May 2017 12:35

RNS Number : 1525F
Graphene NanoChem PLC
15 May 2017
 

For Immediate Release

15 May 2017

Graphene NanoChem PLC

("Graphene NanoChem" or the "Group")

Issuance of Tranche 2 Loan Notes

and

Update on Debt Rationalisation

Graphene NanoChem plc. (AIM:GRPH), the international provider of nanotechnology performance enhancing solutions for global industries, is pleased to announce that, pursuant to the Subscription Agreement dated 22 December 2016 for the issuance of up to £2.5m of Senior Unsecured Zero Coupon Convertible Loan Notes ("Loan Notes"), the Group has issued 40 Loan Notes ("Loan Notes") to Darwin Capital Limited ("Darwin") under Tranche 2 of the said agreement, effective 12 May 2017. The announcement of Tranche 1 was first announced on 23 December 2016.

The proceeds from the issuance will continue to support the working capital requirements of the Group as it continues to advance the progress of its business turnaround plan as previously announced, particularly in crystallizing opportunities in its water and enhanced polymer divisions.

For each £25,000 loan note issued, the Group will receive 90% of the Par Value, equivalent to £22,500 per individual loan note. The Group may redeem these Loan Notes at 105% of Par Value at any point. The Loan Notes are convertible at Darwin's election into new ordinary shares of 0.01p each in the Group ("Ordinary Shares") at the conversion price, being the lesser of 18.4375 pence per new Ordinary Share or 90% of the arithmetic average of five daily volume weighted average share price calculations selected by Darwin out of the twenty trading days prior to conversion. 

Darwin has also been issued with detachable warrants to subscribe for 1,355,932 new Ordinary Shares in the Group ("Warrants") at an exercise price of 18.4375 pence per new Ordinary Share. The Warrants can be exercised over a five-year period from the date of this announcement.

The Company has provided customary warranties, indemnities and undertakings, including customary negative pledges and anti-dilution protections, to Darwin in connection with the issue of the Loan Notes and Warrants. The Company has also paid an arrangement fee for Tranche 2 to Darwin in connection with the Loan Notes.

It is anticipated that Graphene Nanochem will receive net proceeds of approximately £850,000 pursuant to the second tranche of the Loan Notes.

Further announcements will be made in due course, including upon conversion.

Update on debt rationalization

The Company expects the successful debt restructuring exercise it has undertaken to now be unconditional by the end of the 2nd quarter 2017 post completion of the administrative process and other conditions precedent, including non-core asset sales, as previously announced.

The Group's CEO, Jespal Deol commented: "We are pleased with the Tranche 2 drawdown by Darwin further validating the continued progress that we have made in advancing our business including our water and enhanced polymer divisions. These funds raised will allow us to effectively focus on crystallizing the opportunities that we have been working on."

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR").

For further information:

Graphene NanoChem

Tel: +603 2282 3080

Jespal Deol, Chief Executive Officer

 

 

 

Panmure Gordon (NOMAD and Broker)

 

Adam James / Tom Salvesen

Tel: +44 (0) 20 7886 2500

 

 

Yellow Jersey PR Limited (Media)

Tel: +44 (0)7544 275 882

Dominic Barretto / Harriet Jackson

 

 

About Graphene NanoChem

Graphene Nanochem plc (AIM: GRPH), is an international provider of nanotechnology performance enhancing solutions for global industries. The Group employs nanoprocesses and nanomaterials to design, engineer and enhance the performance of mainstream products for a wide range of industrial applications. It has established two major functional platforms in the energy and water sectors, and the Group, through partnerships with established industry players, is focused on building market opportunities in both sectors whilst continuing its developmental work in other strategic application areas of nanotechnology.

Headquartered in Malaysia, Graphene Nanochem was admitted to the AIM of the London Stock Exchange on 26 March 2013, following the reverse acquisition of Biofutures International plc, and trades under the symbol GRPH.L. To find out more, please visit www.graphenenanochem.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODEAFSSFDDXEFF
Date   Source Headline
9th Apr 200911:50 amRNSHolding(s) in Company
20th Feb 20099:07 amRNSRe Contract
13th Feb 20091:46 pmRNSHolding(s) in Company
11th Feb 20095:25 pmRNSHolding(s) in Company
10th Feb 20098:43 amRNSHolding(s) in Company
6th Feb 20095:15 pmRNSHolding(s) in Company
14th Jan 20098:39 amRNSHolding(s) in Company
5th Jan 200912:09 pmRNSDirectors' Share Purchases
17th Nov 200812:08 pmRNSStatement re Commencement of Refinery Project
4th Nov 20082:55 pmRNSTrading Update
29th Sep 200810:49 amRNSInterim Results
29th Aug 20085:05 pmRNSGrant of Options
30th Jul 200811:32 amRNSAGM Statement
22nd Jul 200810:00 amRNSHolding in Company
30th Jun 200812:00 pmRNSHolding in Company
27th Jun 200812:24 pmRNSPosting of Annual Report and
24th Jun 200811:39 amRNSFinal Results
18th Jun 20087:00 amRNSHolding in Company
6th Jun 200812:30 pmRNSEGM Statement
20th May 20084:35 pmRNSNotice of EGM
16th May 20084:35 pmRNSLand In Malaysia
16th May 20081:48 pmRNSHolding(s) in Company
10th Apr 200810:45 amRNSHolding(s) in Company
4th Mar 20083:13 pmRNSHolding in Company
4th Mar 20087:02 amRNSHolding in Company
6th Feb 20088:07 amRNSBoard Appointment
19th Dec 20079:55 amRNSBoard Change
1st Nov 20072:55 pmRNSChange of NOMAD
27th Sep 20077:04 amRNSInterim Results
31st Aug 20074:58 pmRNSChange of NOMAD
31st Aug 20078:38 amRNSTotal Voting Rights
28th Aug 20078:48 amRNSChange of registered address
17th Aug 20075:00 pmRNSAIM Rule 26
1st Aug 20078:57 amRNSUpdate
30th Jul 20073:55 pmRNSResult of AGM
30th Jul 200710:27 amRNSTrading Statement
2nd Jul 20073:39 pmRNSNotice of AGM
28th Jun 20074:27 pmRNSAnnual Report and Accounts
21st Jun 20077:01 amRNSFinal Results
3rd May 200710:47 amRNSPhillip Carter
2nd May 20071:37 pmRNSPhillip Carter
20th Mar 200711:27 amRNSHolding(s) in Company
9th Mar 20072:38 pmRNSLaunch of Biofutures Website
9th Mar 200711:40 amRNSHolding(s) in Company
1st Mar 20077:07 amRNSMembership of RSPO
23rd Feb 20077:01 amRNSBoard Changes
9th Feb 20072:41 pmRNSNon Exec Director Appointment
30th Jan 20071:01 pmRNSContract
23rd Jan 20073:30 pmRNSDirector's Shareholding
6th Dec 20062:51 pmRNSVoting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.